
Company valuation, historical trends, and peer comparisons.
According to Pacific Biosciences of California, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.41B. This represents a change of 25.45% compared to the average of 1.13B of the last 4 quarters.
The mean historical Enterprise Value of Pacific Biosciences of California, Inc. over the last ten years is 1.94B. The current 1.41B Enterprise Value has changed -26.95% with respect to the historical average. Over the past ten years (40 quarters), PACB's Enterprise Value was at its highest in in the June 2021 quarter at 7.30B. The Enterprise Value was at its lowest in in the March 2018 quarter at 242.14M.
Average
1.94B
Median
1.19B
Minimum
229.76M
Maximum
4.66B
Discovering the peaks and valleys of Pacific Biosciences of California, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 420.24%
Maximum Annual Enterprise Value = 4.66B
Minimum Annual Increase = -65.47%
Minimum Annual Enterprise Value = 229.76M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.26B | 12.31% |
| 2024 | 1.12B | -65.47% |
| 2023 | 3.24B | 31.78% |
| 2022 | 2.46B | -47.21% |
| 2021 | 4.66B | 9.78% |
| 2020 | 4.25B | 420.24% |
| 2019 | 816.03M | -17.94% |
| 2018 | 994.45M | 332.81% |
| 2017 | 229.76M | -32.04% |
| 2016 | 338.10M | -63.47% |
The current Enterprise Value of Pacific Biosciences of California, Inc. (PACB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.87B
5-year avg
2.55B
10-year avg
1.94B
Pacific Biosciences of California, Inc.’s Enterprise Value is greater than Quantum-Si incorporated (247.98M), less than Illumina, Inc. (35.71B), greater than Bionano Genomics, Inc. (16.64M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 247.98M | $268.38M | |
| 35.71B | $34.68B | |
| 16.64M | $13.66M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacific Biosciences of California, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pacific Biosciences of California, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pacific Biosciences of California, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Pacific Biosciences of California, Inc. (PACB)?
What is the 3-year average Enterprise Value for Pacific Biosciences of California, Inc. (PACB)?
What is the 5-year average Enterprise Value for Pacific Biosciences of California, Inc. (PACB)?
How does the current Enterprise Value for Pacific Biosciences of California, Inc. (PACB) compare to its historical average?